Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

This is an attempt to deviate from that precedent,” said Daniel Maland, the immediate-past co-chair of the Florida Bar ...

A rival CEO's confrontational social media post underscored the high stakes in the race to develop and deploy cancer ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

The good news is that if you're willing to put in a bit of effort, it's very possible to improve on your process to secure ...

GC Therapeutics has entered gameplay with the mission of unlocking a new generation of cell therapies, uploading with $75 ...

The Federal Reserve yesterday cut interest rates by 50 basis points, in its first time cutting rates in four years. And how ...

The biotech has been the subject of heavy insider buying this month, including by CEO Sergio Traversa, who purchased roughly $395,000 worth of shares at $2.82 each on Sept. 11. That marked the CEO ...

The fall flurry of biotech IPOs shows no signs of abating, with Upstream Bio becoming the latest company to express an ...

Krystal Biotech , Inc. (NASDAQ:KRYS) has reported a significant sale of shares by President and CEO Krishnan Krish S, according to a recent SEC filing. Krishnan offloaded a total of $4,944,237 worth ...

suggesting the potential multiple roles of CM24 in overcoming immune evasion,” stated Purple Biotech CEO Gil Efron. “Moreover, these data enable us to potentially design biomarker- guided ...

NEWS Biotech CEO Sent $1M in Crypto to Wrong Wallet. Now He's Suing the Issuer for Its Return “This is an attempt to deviate from that precedent,” said Daniel Maland, the immediate-past co ...